HPR56 Challenges of Funding Orphan Medicinal Products in Canada: Quantification of Approval Rate and Reimbursement
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.982
https://www.valueinhealthjournal.com/article/S1098-3015(22)01183-4/fulltext
Section Title :
Section Order :
10888
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01183-4&doi=10.1016/j.jval.2022.04.982